Reduced Expression of the NMDA Receptor-Interacting Protein SynGAP Causes Behavioral Abnormalities that Model Symptoms of Schizophrenia

被引:79
作者
Guo, Xiaochuan [1 ,2 ]
Hamilton, Peter J. [3 ]
Reish, Nicholas J. [1 ,2 ,4 ]
Sweatt, J. David [1 ,2 ]
Miller, Courtney A. [1 ,2 ]
Rumbaugh, Gavin [1 ,2 ,3 ]
机构
[1] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA
[2] Univ Alabama, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA
[3] UAB, Summer Program Neurosci SPIN, Birmingham, AL USA
[4] UAB, Med Scientist Training Program MSTP, Birmingham, AL USA
关键词
schizophrenia; NMDA receptor; postsynaptic density; plasticity; hyperactivity; fear conditioning; GTPASE-ACTIVATING PROTEIN; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; GLUTAMATE-RECEPTOR; AMPA RECEPTORS; POSTSYNAPTIC DENSITY-95; KINASE-II; MICE; TRAFFICKING; RAS;
D O I
10.1038/npp.2008.223
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Abnormal function of NMDA receptors is believed to be a contributing factor to the pathophysiology of schizophrenia. NMDAR subunits and postsynaptic-interacting proteins of these channels are abnormally expressed in some patients with this illness. In mice, reduced NMDAR expression leads to behaviors analogous to symptoms of schizophrenia, but reports of animals with mutations in core postsynaptic density proteins having similar a phenotype have yet to be reported. Here we show that reduced expression of the neuronal RasGAP and NMDAR-associated protein, SynGAP, results in abnormal behaviors strikingly similar to that reported in mice with reduced NMDAR function. SynGAP mutant mice exhibited nonhabituating and persistent hyperactivity that was ameliorated by the antipsychotic clozapine. An NMDAR antagonist, MK-801, induced hyperactivity in normal mice but SynGAP mutants were less responsive, suggesting that NMDAR hypofunction contributes to this behavioral abnormality. SynGAP mutants exhibited enhanced startle reactivity and impaired sensory-motor gating. These mice also displayed a complete lack of social memory and a propensity toward social isolation. Finally, SynGAP mutants had deficits in cued fear conditioning and working memory, indicating abnormal function of circuits that control emotion and choice. Our results demonstrate that SynGAP mutant mice have gross neurological deficits similar to other mouse models of schizophrenia. Because SynGAP interacts with NMDARs, and the signaling activity of this protein is regulated by these channels, our data in dicate that SynGAP lies downstream of NMDARs and is a required intermediate for normal neural circuit function and behavior. Taken together, these data support the idea that schizophrenia may arise from abnormal signaling pathways that are mediated by NMDA receptors. Neuropsychopharmacology (2009) 34, 1659-1672; doi:10.1038/npp.2008.223; published online 14 January 2009
引用
收藏
页码:1659 / 1672
页数:14
相关论文
共 73 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]  
[Anonymous], 1994, DIAGN STAT MAN MENT
[3]  
ASTRUP C, 1962, SCHIZOPHRENIA CONDIT
[5]  
Ballard TM, 2002, J NEUROSCI, V22, P6713
[6]   Synaptic Ras GTPase activating protein regulates pattern formation in the trigeminal system of mice [J].
Barnett, MW ;
Watson, RF ;
Vitalis, T ;
Porter, K ;
Komiyama, NH ;
Stoney, PN ;
Gillingwater, TH ;
Grant, SGN ;
Kind, PC .
JOURNAL OF NEUROSCIENCE, 2006, 26 (05) :1355-1365
[7]   Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders [J].
Beneyto, Monica ;
Kristiansen, Lars V. ;
Oni-Orisan, Akinwunmi ;
McCullumsmith, Robert E. ;
Meador-Woodruff, James H. .
NEUROPSYCHOPHARMACOLOGY, 2007, 32 (09) :1888-1902
[8]   Anxiety disorders in schizophrenia [J].
Braga, RJ ;
Petrides, G ;
Figueira, I .
COMPREHENSIVE PSYCHIATRY, 2004, 45 (06) :460-468
[9]   ACTIVITY-DEPENDENT DECREASE IN NMDA RECEPTOR RESPONSES DURING DEVELOPMENT OF THE VISUAL-CORTEX [J].
CARMIGNOTO, G ;
VICINI, S .
SCIENCE, 1992, 258 (5084) :1007-1011
[10]   A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II [J].
Chen, HJ ;
Rojas-Soto, M ;
Oguni, A ;
Kennedy, MB .
NEURON, 1998, 20 (05) :895-904